U.S. markets open in 6 hours 6 minutes

Bioventus Inc. (BVS)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
13.75-0.23 (-1.65%)
At close: 4:00PM EDT
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Currency in USD

Valuation Measures

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
 
As of Date: 4/10/2021
Current
Market Cap (intraday) 5
781.35M
Enterprise Value 3
882.89M
Trailing P/E
45.44
Forward P/E 1
16.18
PEG Ratio (5 yr expected) 1
N/A
Price/Sales (ttm)
2.32
Price/Book (mrq)
5.49
Enterprise Value/Revenue 3
2.75
Enterprise Value/EBITDA 7
16.26

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 3-25.41%
S&P500 52-Week Change 349.51%
52 Week High 319.51
52 Week Low 310.74
50-Day Moving Average 314.00
200-Day Moving Average 314.25

Share Statistics

Avg Vol (3 month) 3383.66k
Avg Vol (10 day) 395.64k
Shares Outstanding 541.04M
Implied Shares Outstanding 656.83M
Float 6.75M
% Held by Insiders 131.62%
% Held by Institutions 153.01%
Shares Short (Mar 14, 2021) 4973.35k
Short Ratio (Mar 14, 2021) 43.09
Short % of Float (Mar 14, 2021) 44.47%
Short % of Shares Outstanding (Mar 14, 2021) 41.71%
Shares Short (prior month Feb 11, 2021) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2020
Most Recent Quarter (mrq)Dec 30, 2020

Profitability

Profit Margin 5.11%
Operating Margin (ttm)6.79%

Management Effectiveness

Return on Assets (ttm)2.82%
Return on Equity (ttm)10.16%

Income Statement

Revenue (ttm)321.16M
Revenue Per Share (ttm)65.54
Quarterly Revenue Growth (yoy)1.10%
Gross Profit (ttm)233.52M
EBITDA 42.99M
Net Income Avi to Common (ttm)4.38M
Diluted EPS (ttm)N/A
Quarterly Earnings Growth (yoy)-50.80%

Balance Sheet

Total Cash (mrq)86.84M
Total Cash Per Share (mrq)2.12
Total Debt (mrq)204.45M
Total Debt/Equity (mrq)141.82
Current Ratio (mrq)1.73
Book Value Per Share (mrq)N/A

Cash Flow Statement

Operating Cash Flow (ttm)71.8M
Levered Free Cash Flow (ttm)42.52M